-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$60.636.91% Upside
Recent Analyst Forecasts and Stock Ratings
Revolution Medicines, Inc. Frequently Asked Questions
-
What analysts cover Revolution Medicines, Inc.?
Revolution Medicines, Inc. has been rated by research analysts at Piper Sandler, H.C. Wainwright, Guggenheim, Oppenheimer, Needham, Wedbush in the past 90 days.